A meta-analysis of 33 clinical trials found that supplementation with inulin-type fructans significantly reduced FBG, HbA1c, fasting insulin, and HOMA-IR in individuals with prediabetes and T2DM. The gene discussed is INS; the disease is type 2 diabetes mellitus.